News Focus
News Focus
icon url

cwell338

02/27/14 10:13 AM

#15980 RE: Tinkerer #15978

STAY FAR AWAY 2.5B SHARES OS 2B IN FLOAT NO REVS 150M IN 144. IRONRIDGE OVER 500M SHARES LEFT!!!!! Stay away sir!!! 4th quarter coming ugly ugly ugly! Save ur $!!!
icon url

Cats83

02/27/14 10:33 AM

#15981 RE: Tinkerer #15978

NATURALLY THE COMPANY IS DEAD AS IT HAS 1B SHARES OUTSTANDING 800M IN THE FLOAT AND BERENBERG HAS 50M SHARES, FRITZ 15M, AND ZAMPETTI 25M! SStAY AWAY!!!!!!!!!!!
icon url

Bsav88atty

02/27/14 11:34 AM

#15982 RE: Tinkerer #15978

Per some opinions I've read, perhaps you should lower your bid to a nickle...
icon url

coolerheadsprevail

02/28/14 2:52 AM

#16010 RE: Tinkerer #15978

I asked this a while back, and ask again today: is SCRC worth investing in at 10 cents/share or not? I am thinking about throwing in a buy order around 8 or 10 cents and seeing if it gets filled, but I don't want to buy into a losing, going-nowhere company. Right now the stock is nearly dead. Any thoughts? TIA.


@Tink,

I had replied to your previous post asking the same question about an entry point at .12. I replied that I believed that at .12, the risk-reward was tolerable and worth a speculative investment at this time. If you are looking for .10 or .08, I honestly don’t know if you’ll get it, but certainly the risk-reward improves at those price points. For your reference, here it is again:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97346327

But remember, SCRC is a development stage enterprise. It is far too early to conclude one way or the other as to whether it is a "losing, going nowhere company". I believe SCRC is making its best effort to succeed, but whether it will (at least to the level of "success" that most shareholders define it to be) or not is TBD. This is a spec penny play. No different than any other.

If you are looking for something to trigger a runup within the next week, then I don't know if there is anything here w/SCRC that can trigger this in that timeframe. But I do know that there are several potentially near-term catalysts that many shareholders are waiting for, such as news of first Hong Kong sales or news of regulatory approval for RapiMeds in mainland China, to name two. How near-term? No clue. Just like none of us have any clue when the Court will rule on the MSJ in the WDDD/ATVI case even though everyone's been expecting it "any day now" for months, LOL!

Hope this helps...